Expensify, Inc.
For the period ended Sep 30, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 6, 2025
EXFY$1.85-9.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
| As of September 30, | As of December 31, | |
|---|---|---|
| 2025 | 2024 | |
| Assets | ||
| Cash and cash equivalents | $61,453 | $48,772 |
| Accounts receivable, net | 12,312 | 12,701 |
| Settlement assets, net | 53,283 | 42,406 |
| Prepaid expenses | 4,174 | 12,089 |
| Other current assets | 21,376 | 20,908 |
| Total current assets | 152,598 | 136,876 |
| Capitalized software, net | 14,622 | 16,232 |
| Property and equipment, net | 13,201 | 13,621 |
| Lease right-of-use assets | 4,912 | 5,441 |
| Deferred tax assets, net | 497 | 499 |
| Other assets | 1,005 | 1,011 |
| Total assets | $186,835 | $173,680 |
| Liabilities and stockholders' equity | ||
| Accounts payable | $710 | $196 |
| Accrued expenses and other liabilities | 7,726 | 8,240 |
| Lease liabilities, current | 720 | 729 |
| Settlement liabilities | 35,238 | 28,845 |
| Total current liabilities | 44,394 | 38,010 |
| Lease liabilities, non-current | 5,208 | 5,738 |
| Other liabilities | 1,573 | 1,689 |
| Total liabilities | 51,175 | 45,437 |
| Commitments and contingencies (Note 4) | ||
| Stockholders' equity: | ||
| Preferred stock, par value $0.0001; 10,000,000 shares authorized as of September 30, 2025 and December 31, 2024; no shares issued and outstanding as of September 30, 2025 and December 31, 2024 | — | — |
| Common stock, par value $0.0001 Class A common stock; 1,000,000,000 shares authorized; 80,832,770 and 79,471,414 shares of Class A common stock issued and outstanding as of September 30, 2025 and December 31, 2024, respectively LT10 common stock; 21,871,197 shares authorized; 4,209,827 shares of LT10 common stock issued and outstanding as of September 30, 2025 and December 31, 2024LT50 common stock; 24,967,114 shares authorized; 7,988,939 and 7,695,524 shares of LT50 common stock issued and outstanding as of September 30, 2025 and December 31, 2024, respectively | 9 | 9 |
| Additional paid-in capital | 300,751 | 279,062 |
| Accumulated deficit | (165,100) | (150,828) |
| Total stockholders' equity | 135,660 | 128,243 |
| Total liabilities and stockholders' equity | $186,835 | $173,680 |
See accompanying notes to Condensed Consolidated Financial Statements.
2
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.